Clinical Professor
Division Chief

Undergraduate: UNC, Chapel Hill, NC
Medical School: UNC, Chapel Hill, NC
Residency: UNC, Chapel Hill, NC

Board Certified in General Obstetrics & Gynecology, and Gynecologic Oncology by the American Board of Obstetrics & Gynecology

Clinical Services

• Gynecologic Oncology
• • diagnosis of women with cancer of the reproductive organs
  • treatment of women with cancer of the reproductive organs
  • • surgery
    • chemotherapy

Research Interests

• Ovarian cancer
• Endometrial (uterus) cancer
• Cervical cancer

Curriculum Vitae

Selected Publications

Homesley HD, Filiaci V, Markman M, Bitterman P, Eaton L, Kilgore LC, Monk BJ, Ueland FR; Gynecologic Oncology Group.Phase III trial of ifosfamide with or without paclitaxel in advanced uterine carcinosarcoma: a Gynecologic Oncology Group Study.J Clin Oncol. 2007 Feb 10;25(5):526-31.

Homesley HD, Blessing JA, Sorosky J, Reid G, Look KY. Phase II trial of liposomal doxorubicin at 40 mg/m(2) every 4 weeks in endometrial carcinoma: a Gynecologic Oncology Group Study. Gynecol Oncol. 2005 Aug;98(2):294-8.

3: Sutton G, Axelrod JH, Bundy BN, Roy T, Homesley HD, Malfetano JH, Mychalczak BR, King ME. Whole abdominal radiotherapy in the adjuvant treatment of patients with stage III and IV endometrial cancer: a gynecologic oncology group study. Gynecol Oncol. 2005 Jun;97(3):755-63.

Thigpen JT, Brady MF, Homesley HD, Malfetano J, DuBeshter B, Burger RA, Liao S. Phase III trial of doxorubicin with or without cisplatin in advanced endometrial carcinoma: a gynecologic oncology group study.J Clin Oncol. 2004 Oct 1;22(19):3902-8.

Tate Thigpen J, Blessing JA, DeGeest K, Look KY, Homesley HD; Gynecologic Oncology Group. Cisplatin as initial chemotherapy in ovarian carcinosarcomas: a Gynecologic Oncology Group study. Gynecol Oncol. 2004 May;93(2):336-9.

Homesley HD, Boike G, Spiegel GW. Feasibility of laparoscopic management of presumed stage I endometrial carcinoma and assessment of accuracy of myoinvasion estimates by frozen section: a gynecologic oncology group study. Int J Gynecol Cancer. 2004 Mar-Apr;14(2):341-7.

Homesley HD, Hall DJ, Martin DA, Lewandowski GS, Vaccarello L, Nahhas WA, Suggs CL, Penley RG. A dose-escalating study of weekly bolus topotecan in previously treated ovarian cancer patients. Gynecol Oncol. 2001 Nov;83(2):394-9.

Thigpen T, Brady MF, Homesley HD, Soper JT, Bell J. Tamoxifen in the treatment of advanced or recurrent endometrial carcinoma: a Gynecologic Oncology Group study. J Clin Oncol. 2001 Jan 15;19(2):364-7.

Thigpen JT, Brady MF, Alvarez RD, Adelson MD, Homesley HD, Manetta A, Soper JT, Given FT. Oral medroxyprogesterone acetate in the treatment of advanced or recurrent endometrial carcinoma: a dose-response study by the Gynecologic Oncology Group. J Clin Oncol. 1999 Jun;17(6):1736-44.

Burger RA, DiSaia PJ, Roberts JA, O'rourke M, Gershenson DM, Homesley HD, Lichtman SM, Barnes W, Moore DH, Monk BJ. Phase II trial of vinorelbine in recurrent and progressive epithelial ovariancancer. Gynecol Oncol. 1999 Feb;72(2):148-53.PMID

Homesley HD, Bundy BN, Hurteau JA, Roth LM. Bleomycin, etoposide, and cisplatin combination therapy of ovarian granulosa cell tumors and other stromal malignancies: A Gynecologic Oncology Group study. Gynecol Oncol. 1999 Feb;72(2):131-7.

Lentz SS, Homesley HD. Gynecologic problems in older women. Clin Geriatr Med. 1998 May;14(2):297-315. Review.